Dr. Alfred Slanetz is the founder, president, and chief executive officer of Geneius and has been since its incorporation. He also has served as a director on Geneius’s board since its incorporation in 2012. Geneius, an immuno-oncology start-up, is researching ways to help cancer patients’ immune systems detect and attack…...
Will Liu, Ph.D.
Dr. Will Liu is a Partner of Eight Roads Ventures China, specializing in healthcare investment. Dr. Liu has twenty years of experience in the pharmaceutical and biotech industries, both in R&D and in business development. Prior to joining Eight Roads, he held several positions of business development in multinational pharmaceutical…...
Brian Leyland-Jones, MBBS, Ph.D.
Brian Leyland-Jones, BSc (Ist class Hons), MBBS, PhD, FRACP, FRCPC is the Chief Medical Officer of AIM-HI Accelerator Fund and the N OF 1 Mission, CSO of The Darwin Foundation, collectively devoted to the implementation of prevention and cure of malignancy globally. He sits on several national and international boards…...
Raju Kucherlapati, Ph.D.
Since 2001 Dr. Kucherlapati is the Paul C. Cabot Professor of Genetics and Professor of Medicine at Harvard Medical School and was the first Scientific Director of the Harvard Medical School-Partners HealthCare Center for Genetics and Genomics (HPCGG). Dr. Kucherlapati received his Ph.D. from the University of Illinois at Urbana…...
Wai-Kwan Alfred Yung, M.D., Chair
Dr. Yung is a professor of Neuro-Oncology at The University of Texas MD Anderson Cancer Center, where he holds the Margaret and Ben Love Chair of Clinical Cancer Care. He was chair of the Department of Neuro-oncology (1999-2015) and co-director (1999-2015) of the MDACC Brain Tumor Center. During his tenure,…...
Yong (Ben) Ben, M.D., MBA
Yong (Ben) Ben, M.D., MBA, has over 20 years of medical experience in academia and pharmaceutical & biotech companies, including clinical practice, drug discovery and development in oncology. He joined BeiGene in February 2019 as Chief Medical Officer, Immuno-Oncology. Prior to joining BeiGene, Dr. Ben served as Chief Medical Officer…...
Webster Cavenee, Ph.D.
Dr. Webster Cavenee did his graduate and postdoctoral training in cell biology, biochemistry and human genetics. He received his Ph.D. with honors in 1977 from the University of Kansas Medical School and then did postdoctoral work at the Jackson Laboratory, Massachusetts Institute of Technology and Howard Hughes Medical Institute at…...
Kwok Wai Leung, Ph.D.
Dr. Leung is the Chief Financial Officer of the Asian Fund for Cancer Research Limited, who oversees the accounting, financial, and administrative operations of the organization; and directly assists on all strategic and tactical matters as they relate to budget management and the securing of new funding. Dr. Leung has…...
Hali Hartmann, Ph.D.
Dr. Hali Hartmann is Director of Scientific Relations with the Asian Fund for Cancer Research. In these capacities Dr. Hartmann manages AFCR’s science departments, including their grant, proposal and review programs. She serves as the liaison with sponsored scientists and their universities and oversees management of multiple sponsored programs. With…...
Zeting Wang, M.B.A.
Ms. Zeting Wang is the Director of Direct Response of the Asian Fund for Cancer Research, where she manages all direct response fundraising and campaign related job responsibilities for acquisition, retention, monthly giving and online giving programs. She too serves in the same capacity with the National Foundation for Cancer…...
